NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
Related Articles
- World Conference in Nephrology Videos on Home Dialysis Posted 04-14-2026
- Vantive’s PD Catheter: Timing, Tips, and Techniques Webinar Posted 04-14-2026
- DaVita Has a New PD Loss-predictive AI Model to Identify Patients at Risk Posted 04-14-2026
- ISPD’s Spotlight Webinar Series 2026 Posted 03-12-2026

